One previous clinical trial in humans also showed that add-on low-dose memantine may improve the plasma level of TNF-α and restore the clinical cognitive functions in bipolar II disorder [54,55], indicating a similar modulating effect of memantine on the inflammation and cognitive symptoms in different diseases. This evidence concerns the gene TNF and bipolar II disorder.